Penicillin-Streptomycin Solution
Referencia BMC1030-100
embalaje : 100mL
Marca : Abbkine
Contact local distributor :
Teléfono : +1 850 650 7790
Specification
| Product name | Penicillin-Streptomycin Solution |
| Applications | Cell culture |
| SampleType | Mammalian cells |
Product Properties
| Formulation | Liquid solution |
| Kit components | •Penicillin-Streptomycin Solution |
| Features & Benefits | • Ready-to-use, It was filtered with a 0.1 μm filter membrane and could be added directly to the cell culture medium. |
| Storage instructions | Stored at -20℃ for 12 months. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
Additional Information
| Background | Penicillin Streptomycin Solution, also commonly referred to as "double antibody", is the most commonly used antibiotic in vitro culture to prevent microbial contamination, and is often formulated to 100 times the concentration of mother liquor. Among them, penicillin can interfere with the synthesis of bacterial cell wall, and is especially effective against gram-positive bacteria. Streptomycin can bind to the 30S subunit of the bacterial ribosome, inhibit the synthesis of bacterial proteins, and is effective against both gram-negative and Gram-positive bacteria, but is particularly effective against Gram-negative bacteria. |
Image & description
-
View
Multimodal enhancement of ferroptosis for synergistic cascade colorectal cancer therapy.(BMC1030-13)
Author：Wu, Ziying, et al. Publication name：Chemical Engineering Journal IF：13
-
View
Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation(BMC1030-12.9)
Author：潘细儿 Publication name：Frontiers in immunology IF：12.9
-
View
FOXA2 regulated by HDAC3-mediated deacetylation attenuates neuropathic pain by modulating microglial lipid metabolism and synaptic pruning dysregulation(BMC1030-10.1)
Author：Hui Zeng Publication name：Diabetes Metabolic Syndrome and Obesity IF：10.1
-
View
An RNA G-quadruplex within the sclerostin 3′ untranslated region enhances sclerostin expression by blocking miR-4648 binding.(BMC1030-8.5)
Author：Duan, Xuan, et al. Publication name：International Journal of Biological Macromolecules IF：8.5
-
View
Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264. 7 macrophages and analysis of anti-osteoclastogenesis potential of chrysin.(BMC1030-2.7)
Author：Ahmad, Syed Sufian, et al. Publication name：Iranian Journal of Basic Medical Sciences IF：2.7
Reviews
There are no reviews yet.